Arkolith/Insider Trading/RIGL/Form 4

Moos Walter H

DirectorRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Feb 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$145K
Net Open-Market Flow
-$145K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)4K$24.00$96K17K
Feb 20, 2026Sell(S)4K$36.36$145K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)4K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-001015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML